Robot-assisted vs. video-assisted thoracoscopic surgery in lung cancer
Original Article

Robot-assisted vs. video-assisted thoracoscopic surgery in lung cancer

Masahiro Miyajima, Ryunosuke Maki, Wataru Arai, Kodai Tsuruta, Yuma Shindo, Yasuyuki Nakamura, Atsushi Watanabe

Department of Thoracic Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan

Contributions: (I) Conception and design: M Miyajima; (II) Administrative support: A Watanabe; (III) Provision of study materials or patients: M Miyajima; (IV) Collection and assembly of data: M Miyajima; (V) Data analysis and interpretation: M Miyajima; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.

Correspondence to: Masahiro Miyajima, MD. Department of Thoracic Surgery, Sapporo Medical University School of Medicine, South 1, West 16, Chuo-ku, Sapporo, Hokkaido 060-8543, Japan. Email: miyajima@sapmed.ac.jp.

Background: The major advantages of robot-assisted surgery are the fine field of view provided by the high-precision three-dimensional (3D) images and the good operability provided by the robotic arms that enables precise movements. A growing number of retrospective studies have compared robotic-assisted thoracoscopic surgery (RATS) with video-assisted thoracoscopic surgery (VATS), but the number of cases is limited and the results are contradictory.

Methods: We studied the medical records of primary lung cancer patients who underwent lobectomy with lymph node dissection between 2017 and 2020. Four hundred and eleven patients fulfilled the inclusion criteria in this study (RATS: 103; VATS: 308). We compared the perioperative factors and postoperative results of the VATS and RATS groups. Further, we adjusted background factors using propensity score matching (PSM) then compared the results of 200 patients (100 patients in each group). In this study, we matched interlobar fissure completeness, which affects operative difficulty and operative time; however, this has been superficially compared in previous studies.

Results: After PSM, a significant difference was observed in the intraoperative blood loss (RATS: 53.3 mL, VATS: 120.3 mL, P=0.04). The rates of surgical complications were comparable between the groups (10.0% vs. 13.0%, P=0.66) with similar mean operation times (RATS: 215.0 min, VATS: 210.1 min, P=0.57). The mean postoperative stay in the RATS group was shorter than that in the VATS group (10.0 vs. 11.5 days, P=0.04).

Conclusions: Initial experience of RATS had no obvious drawbacks when compared with that of VATS on propensity-matched analysis.

Keywords: Video-assisted thoracoscopic surgery (VATS); robot-assisted thoracoscopic surgery (RATS); lung cancer; lung resection


Submitted Oct 26, 2021. Accepted for publication May 19, 2022.

doi: 10.21037/jtd-21-1696


Video 1 We perform intraluminal ligation of the proximal part of the pulmonary artery branches and seal and cut off the periphery using the daVinci vessel sealing system.

Introduction

Robotic-assisted thoracoscopic surgery (RATS) is characterized by its excellent field of view and the maneuverability of its robotic arms, which can move accurately even in a narrow surgical field. Although it is common in laparoscopic surgery, pressure insufflation with carbon dioxide gas (CO2) also contributes to a better operative field and may reduce blood loss. Moreover, operators can control the camera by themselves in RATS, which enables the development of an ideal field of view. Thus, RATS has the potential to contribute to surgical safety. However, a limited number of high-quality, large-scale randomized trials were reported. Although there are a growing number of retrospective studies comparing RATS and video-assisted thoracoscopic surgery (VATS), the results are conflicting and many reports are limited to including a small number of cases (1-3). Moreover, it is quite difficult to eliminate selection bias in these papers. In this study, we matched interlobar fissure completeness, which increases operative difficulty, operative complications, and operative time; however, this has been superficially compared in previous studies.

Therefore, we evaluated the perioperative outcomes of RATS and VATS lobectomies for lung cancer using a propensity score-matched analysis.

The rapid increase in RATS has led to the development of new and useful devices. However, the surgery employing these devices; daVinci Staplers and vessel sealing system (VSS) have not yet been fully explored. RATS allows the operator to perform the treatment with the superior maneuverability provided by the robotic arms. However, the assistant is blocked by the robotic arms, making it difficult to perform the procedures. To overcome this disadvantage, we developed solo surgery by the operator that is less dependent on an assistant in the operative field.

The pulmonary artery (PA) is usually treated with staplers or hemoclips in RATS lobectomy, and there are few reports of intraluminal ligation of the PA. At our institute, we perform intraluminal ligation of the proximal part of the PA branches and seal and cut off the periphery using the da Vinci VSS (Video 1). Moreover, we used the da Vinci stapler for fissure division and bronchial stapling by an operator rather than hand-held staplers, reducing the assistant’s stapler use.

In this study, we compared the results of RATS solo lobectomy with VATS lobectomy for lung cancer resection. We present the following article in accordance with the STROBE reporting checklist (available at https://jtd.amegroups.com/article/view/10.21037/jtd-21-1696/rc).


Methods

Subjects and study design

The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The study protocol was approved by the institutional review board of Sapporo Medical University (IRB No. 322-265) and informed consent was waived due to the retrospective nature of the study. This study was a retrospective analysis of patient data from January 2017 to December 2020.

Ultimately, four hundred and eleven patients who underwent pulmonary lobectomy with node dissection were included. Segmentectomy were excluded from the study. Medical records of the patients were reviewed and the precise characteristics were recorded (Table 1). The surgeon graded the fissures prospectively at the time of surgery. From our surgical database, we recorded information regarding the lobe fissure completeness using the Craig and Walker classification. We defined incomplete fissure as an interlobar fissure completeness of ≥3 based on the Craig and Walker classification (4).

Table 1

Patient demographics (n=411)

Characteristics RATS (n=103) VATS (n=308) P value
Age (years), mean (SD) 68.6 (8.9) 70.6 (8.5) 0.04
Sex (male/female), n 53/50 152/156 0.73
BMI (kg/m2), mean (SD) 23.3 (3.4) 23.2 (3.5) 0.67
Smoking status, n 0.90
   Ever 72 211
   Never 31 97
%VC, mean (SD) 112.6 (15.9) 108.0 (16.7) 0.02
FEV1%, mean (SD) 76.4 (11.1) 74.3 (14.8) 0.18
Tumor laterality, n 0.05
   Right 62 219
   Left 41 89
Tumor location, n 0.25
   Right upper lobe 34 133
   Right middle lobe 8 20
   Right lower lobe 20 66
   Left upper lobe 23 51
   Left lower lobe 18 38
Incomplete fissure, n 0.01
   − 97 261
   + 6 47
Clinical stage, n 0.49
   IA1 10 39
   IA2 28 83
   IA3 27 66
   IB 13 42
   IIA 3 17
   IIB or more 22 61
Maximum tumor size (mm), mean (SD) 20.6 (11.8) 24.9 (14.7) 0.01

Incomplete fissure: “−” means absence, and the “+” means presence of the incomplete fissure ≥ grade 3. RATS, robot-assisted thoracoscopic surgery; VATS, video-assisted thoracoscopic surgery; SD, standard deviation; BMI, body mass index; %VC, percent vital capacity; %FEV1, percent forced expired volume in 1 second.

The indications for RATS and VATS lobectomy were clinical T1–T3, N0–N1, and M0. The preoperative assessments for all patients included chest computed tomography (CT) imaging, bronchoscopy, standard hematology and blood chemistry, cardiological examination, pulmonary function test, and brain magnetic resonance imaging or CT. Positron emission tomography (PET)/CT was taken in almost all patients. Abdominal ultrasound and bone scan were performed in cases in which PET/CT was not performed. Using the propensity score matching (PSM), we compared the perioperative outcomes by two different approaches.

Surgical procedure

VATS approach was performed with one mini-thoracotomy and two ports in all cases. A mini-thoracotomy (35 mm) was placed at the level of the fourth intercostal space (ICS). Then, two ports were placed at the sixth and seventh ICS. With respect to processing the PA, the proximal part of the PA branch is ligated with a silk thread. Then, the vessel is divided by the VSS. Regarding mediastinal lymph node dissection (MLND), our technique relies on the VSS, which can help control lymphatic leakage (5).

RATS is usually performed using 4-arm robotic techniques, following the method of Cerfolio et al. (6). This study was limited to surgery using the daVinci Xi. MLND was conducted by a lobar-specific way. ND2a-2 was performed based on the frozen section diagnosis. Postoperative analgesia was provided using an epidural catheter. All patients were administered postoperative nonsteroidal anti-inflammatory drugs (NSAIDs) and ibuprofen at fixed times, adding an opiate in subjects with poor pain control. The epidural catheter was removed when postoperative pain subsided with a visual analogue scale score of 2. The duration of the epidural tube use was used to compare the difference in postoperative pain between the study groups.

A suction pressure of 5 cmH2O was provided to the chest tube. A persistent air leak (PAL) lasting more than 5 days was defined as a postoperative PAL. The chest tube was removed when there was no air leakage, not serum, and less than 6 cc/kg/day.

Statistical analysis

All patients were matched one-to-one between the RATS and the VATS lobectomy groups. The nearest estimated propensity score was employed to minimalize selection bias among patients. Covariates including age, sex, tumor location, smoking status, fissure completeness, body mass index (BMI), percent vital capacity (%VC), percent forced expired volume in 1 second (%FEV1), and maximum tumor diameter were selected to estimate the propensity score. We matched propensity scores one-to-one using nearest-neighbor matching methods without replacement using a 0.20 caliper width. After the matching procedure, 100 patients were selected for each group (VATS and RATS) for statistical analysis.

Descriptive statistics are reported as means for continuous variables and tabulated as frequencies and percentages for categorical variables. All statistical analyses were performed using SPSS for Windows (version 22.0; SPSS, Inc., Chicago, IL, USA). Student’s t-test, χ2 or Fisher’s exact test was performed for analysis. Differences were considered statistically significant at P<0.05.


Results

Patient characteristics in the unmatched cohort

In total, 411 patients fulfilled the inclusion criteria for this study: 103 RATS and 308 VATS lobectomies. Almost two-thirds of patients treated with VATS were on the right side (P=0.05); more patients treated with VATS had incomplete fissures (P=0.01). The average pulmonary function (%VC) was also slightly better in the RATS group than in the VATS group (P=0.02). The maximum tumor size was larger in the VATS group (24.9 vs. 20.6 mm, P=0.01). Age, sex, BMI, smoking status, FEV1, tumor location, and clinical stage were similar (Table 1).

Surgery-related outcomes in the unmatched cohort

Table 2 summarizes the surgery-related outcomes. The surgical complication rates were comparable between the groups (intraoperative, postoperative, P=0.721, P=0.339). Emergent thoracotomy was necessary for seven patients in the VATS group but none in the RATS group. Persistent air leakage was more frequent in the VATS group (RATS: 2.9%, VATS: 9.7%, P=0.03). The mean operation times were 214.9 and 206.9 min in the RATS and VATS groups, respectively; P=0.28. The other surgery-related outcomes were as follows: mean intraoperative blood loss (52.7 vs. 124.2 mL, P<0.001), mean chest tube duration (1.9 vs. 2.6 days, P=0.045), mean postoperative hospital stay (10.1 vs. 12.0 days, P<0.001), number of dissected lymph nodes (total: 20.0 vs. 19.3, mediastinal: 12.1 vs. 11.8, P=0.53 and 0.73, respectively), and the number of mechanical stapler cartridges used (4.3 vs. 4.6, P=0.10) in the RATS and the VATS groups, respectively.

Table 2

Perioperative outcome and number of dissected lymph nodes (n=411)

Characteristics RATS (n=103) VATS (n=308) P value
Operation time (min), mean (SD) 214.9 (56.1) 206.9 (88.2) 0.28
Bleeding amount (mL), mean (SD) 52.7 (94.7) 124.2 (243.5) <0.001
Duration of chest tube (days), mean (SD) 1.9 (2.8) 2.6 (4.1) 0.045
Postoperative stay (days), mean (SD) 10.1 (4.1) 12.0 (5.6) <0.001
Intraoperative complication, n (%) 12 (11.7) 49 (15.9) 0.72
Emergent thoracotomy, n (%) 0 7 (2.3) 0.20
Postoperative complication, n (%) 13 (12.6) 34 (11.0) 0.34
Persistent air leakage, n (%) 3 (2.9) 30 (9.7) 0.03
Number of dissected lymph nodes, mean (SD)
   Total lymph nodes 20.0 (8.6) 19.3 (9.9) 0.53
   Mediastinal lymph nodes 12.1 (7.0) 11.8 (7.7) 0.73
   Mechanical stapler used 4.3 (1.8) 4.6 (2.1) 0.10

RATS, robot-assisted thoracoscopic surgery; VATS, video-assisted thoracoscopic surgery; SD, standard deviation.

Characteristics of the propensity score-matched patients

After PSM, 100 patients were included in each surgical group (n=200). Patient and disease characteristics were well balanced between the groups in the matched cohort (Table 3). Most importantly, we confirmed that interlobar fissure completeness was almost similar between the groups.

Table 3

Patient demographics after PSM (n=200)

Characteristics RATS (n=100) VATS (n=100) P value
Age (years), mean (SD) 68.9 (8.8) 68.8 (9.2) 0.94
Sex (male/female), n 52/48 51/49 0.99
BMI (kg/m2), mean (SD) 23.4 (3.5) 23.0 (3.6) 0.47
Smoking status, n 0.88
   Ever 70 68
   Never 30 32
%VC, mean (SD) 112.3 (15.8) 114.6 (16.5) 0.32
FEV1%, mean (SD) 76.4 (11.1) 76.2 (15.2) 0.92
Tumor laterality, n 0.46
   Right 61 67
   Left 39 33
Primary lobe, n 0.75
   Right upper lobe 33 40
   Right middle lobe 8 5
   Right lower lobe 20 22
   Left upper lobe 23 20
   Left lower lobe 16 13
Incomplete fissure, n 0.99
   − 94 93
   + 6 7
Clinical stage, n 0.45
   IA1 15 14
   IA2 31 30
   IA3 28 19
   IB 9 11
   IIA 3 8
   IIB or more 14 18
Maximum tumor size (mm), mean (SD) 20.5 (11.7) 21.0 (10.9) 0.76
Pathological stage, n 0.21
   IA1 10 18
   IA2 32 23
   IA3 17 17
   IB 18 20
   IIA 0 5
   IIB or more 23 24

Incomplete fissure: “−” means absence, and the “+” means presence of the incomplete fissure ≥ grade 3. PSM, propensity score matching; RATS, robot-assisted thoracoscopic surgery; VATS, video-assisted thoracoscopic surgery; SD, standard deviation; BMI, body mass index; %VC, percent vital capacity; %FEV1, percent forced expired volume in 1 second.

Surgery-related outcomes of the propensity score-matched patients

Table 4 summarizes the surgery-related outcomes. The rates of postoperative complications were comparable between the groups (RATS: 10.0% vs. VATS 13.0%, P=0.66). Emergent thoracotomy was necessary in two cases in the VATS group. There was no emergent thoracotomy in the RATS group. The rates of intraoperative complications were comparable between the groups (RATS: 12.0% vs. VATS 7.0%, P=0.24). Persistent air leakage was comparable (RATS: 3.0%, VATS: 8.0%, P=0.21). The mean operation times were 215.0 and 210.1 min in the RATS and VATS groups, respectively (P=0.57). The other surgery-related outcomes were as follows: mean intraoperative blood loss (53.3 vs. 120.3 mL, P=0.04), mean chest tube duration (1.9 vs. 2.4 days, P=0.31), mean postoperative hospital stay (10.0 vs. 11.5 days, P=0.04); the number of dissected lymph nodes (total: 20.0 vs. 17.6, mediastinal: 12.0 vs. 10.6, P=0.05 and P=0.18, respectively), and the number of mechanical stapler cartridges used during surgery (4.3 vs. 4.6, P=0.25).

Table 4

Perioperative outcome and number of dissected lymph nodes after PSM (n=200)

Characteristics RATS (n=100) VATS (n=100) P value
Operation time (min), mean (SD) 215.0 (56.3) 210.1 (64.9) 0.57
Bleeding amount (mL), mean (SD) 53.3 (95.5) 120.3 (314.7) 0.04
Blood transfusion, n 0 1 0.99
Duration of chest tube (days), mean (SD) 1.9 (2.8) 2.4 (4.3) 0.31
Duration of epidural tube (days), mean (SD) 1.6 (1.2) 1.7 (1.2) 0.86
Postoperative stay (days), mean (SD) 10.0 (4.2) 11.5 (5.6) 0.04
Intraoperative complication, n (%) 12.0 (12.0) 7.0 (7.0) 0.24
Emergent thoracotomy, n (%) 0 2.0 (2.0) 0.50
Postoperative complication, n (%) 10.0 (10.0) 13.0 (13.0) 0.66
   Persistent air leakage, n 3 8 0.21
   Cerebral infarction, n 1 0 0.99
   Arrhythmia, n 2 2 0.99
   Pneumonia, n 1 3 0.62
   Laryngeal nerve palsy, n 1 1 0.99
   Wound trouble, n 2 0 0.50
Number of dissected lymph nodes, mean (SD)
   Total lymph nodes 20.0 (8.7) 17.6 (8.5) 0.05
   Mediastinal lymph nodes 12.0 (7.1) 10.6 (7.4) 0.18
Upstaging of N-factor, n 12 8 0.48
Upstaging of T-factor, n 28 21 0.32
Mechanical stapler used, mean (SD) 4.3 (1.8) 4.6 (2.1) 0.25
Resection completeness, n 0.99
   R0 97 97
   R1 2 2
   R2 1 1

PSM, propensity score matching; RATS, robot-assisted thoracoscopic surgery; VATS, video-assisted thoracoscopic surgery; SD, standard deviation.

Additionally, pathological results were analyzed. Regarding resection completeness, no difference was found between the two groups. The upstaging rate of N factor (12% vs. 8%, P=0.48) and T factor (28% vs. 21%, P=0.32) was compared, and no difference was observed.


Discussion

Thoracoscopic lung resection for lung cancer has shown improved perioperative outcomes and oncological effects similar to open thoracotomy (7-9). RATS is characterized by its high-definition three-dimensional (3D) images and the maneuverability of its robotic arms (9). These features of RATS make the thorough, technically demanding lymph node dissection relatively easy. Although the results are conflicting and many reports are limited to including a small number of cases (2,3). In previous studies using the huge database, RATS was reported to have the advantage of decreased length of stay and decreased conversion rate compared to VATS (10,11). Though propensity matching was performed to reduce the selection bias in these studies, interlobar fissure completeness was not accounted into variables to be matched. We think interlobar fissure completeness affect the operative difficulty and operative time at a non-negligible level.

Therefore, in this study, we tried to reduce the selection bias to use the precise matching that includes the interlobar fissure completeness. In the present study, we observed no demonstrable disadvantages of robotic surgery over the traditional thoracoscopic technique. We observed no difference in surgical complications between the RATS and the VATS groups (intraoperative, postoperative, P=0.24, P=0.66). Emergent thoracotomy was not necessary in the RATS group.

Cerfolio et al. reported that emergent thoracotomy conversions were required in 39 of 632 patients (6.1%) with RATS anatomical lung resection (12). Hence, Ueno reported that three of 192 patients required the emergent thoracotomy conversions due to bleeding with RATS anatomical lung resection (2.3%) (13). In this study, most of the PA injured lesions were peripheral parts of the PA. Therefore, there was no bleeding from PA more than 500 mL. This may have resulted in no emergent thoracotomy conversions in the RATS group. In addition, robotic solo lobectomy for lung cancer was found to dramatically reduce intraoperative blood loss compared to VATS surgery (53.3 vs. 120.3 mL, P=0.04). We believe that the exceptional surgical view made possible by the high-definition 3D images and the careful dissection around PA by the robotic arms contributed to this phenomenon. Although the reduction of intraoperative blood loss did not affect the blood transfusion rate in this study, a clear operative field must have improved the operative quality.

Moreover, in our robotic solo lobectomy, there was no increase in operative time compared to VATS surgery. Swanson et al. showed no differences in surgical complication rates from a multi-hospital database with 295 propensity score-matched cases during VATS and RATS lobectomies (14). Regarding the intraoperative complication, we experienced two vessel injuries resulting from daVinci forceps interference. With the magnified vision, the surgeon must pay attention to the fact that the surgical field view becomes quite narrow. We compared the differences between the VATS and RATS groups in terms of patients’ baseline characteristics (Table 1). As this study includes our initial cases for robotic surgery, we preferred simpler cases for the first 20 cases for RATS lobectomy. We avoided the patients with interlobar fissure incompleteness and clinical node positivity.

Thereafter, we put no bias in patient selection for RATS lobectomy. Moreover, we matched interlobar fissure incompleteness with PSM (Table 3). However, the type of surgery (VATS or RATS) was decided at the discretion of the surgeon, this could affect the outcome of each surgery. Therefore, the inherent selection bias cannot be ruled out.

When the stapler was used, the assistant experienced considerable difficulty when blocked by the robotic arms. To overcome this disadvantage, we developed solo surgery by the operator that is less dependent on assistants in the operative field. In part, this factor might have resulted in the reduction of blood loss in the RATS group.

In thoracoscopic surgery, the ligation of blood vessels is controlled by the tactile sensation directly transmitted to the operator’s hand; However, in RATS, these sensations are not transmitted. Therefore, there is the inherent risk of accidentally damaging blood vessels or threads. However, an experienced operator in thoracoscopic surgery can safely perform surgery by inferring the force applied from the video information.

Nonetheless, it is desirable to have a tactile sensation to enhance the safety and quality of the surgery, which is being gradually developed (15,16). One of the advantages of RATS is its maneuverability, allowing surgeons to perform extensive lymph node resections (17). The number of lymph nodes dissected in this study suggests that it is similar between the RATS and VATS groups. Previous studies have shown the equivalence of two minimally invasive approaches (18). Whereas, some reported the higher upstaging rate in RATS (19). Further randomized prospective studies would be needed (6).

We observed a shorter postoperative stay in the RATS group. Although it may seem long, it is shorter compared to the 15.5 days reported by the Japan Hospital Information Organization database [2020] (20). The difference in postoperative stay could be attributable to the reduction in pain, we are unable to judge the superiority of RATS in this aspect in this study. we did not observe any difference in the duration of epidural tube use. Although many studies reported that RATS showed a more favorable pain control profile compared with thoracotomy, there were no significant difference between RATS and VATS (21,22).

This study has some limitations. First, this study was a single-center retrospective study reviewing medical records. Propensity matching reduced but did not eliminate selection bias, and prospective randomized studies are required. Second, the robot data in this series contains initial experiences that may skew the results, then inherent selection bias cannot be eliminated. However, because of previous experiences of open and thoracoscopic pulmonary resection, as well as the relatively steep learning curve (23), we believe the difference in experience between the two approaches would be minimized although not eliminated. Third, postoperative pain and long-term survival were not analyzed in this study


Conclusions

The initial experience of RATS lobectomy had no obvious drawbacks compared to VATS technique by propensity score-matched analysis. Moreover, we ascertained that robotic solo lobectomy for lung cancer was safe and effective.


Acknowledgments

Funding: None.


Footnote

Reporting Checklist: The authors have completed the STROBE reporting checklist. Available at https://jtd.amegroups.com/article/view/10.21037/jtd-21-1696/rc

Data Sharing Statement: Available at https://jtd.amegroups.com/article/view/10.21037/jtd-21-1696/dss

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-21-1696/coif). The authors have no conflicts of interest to declare.

Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The study protocol was approved by the institutional review board of Sapporo Medical University (IRB No. 322-265) and informed consent was waived due to the retrospective nature of the study.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


References

  1. Farivar AS, Cerfolio RJ, Vallières E, et al. Comparing robotic lung resection with thoracotomy and video-assisted thoracoscopic surgery cases entered into the Society of Thoracic Surgeons database. Innovations (Phila) 2014;9:10-5. [Crossref] [PubMed]
  2. Louie BE, Farivar AS, Aye RW, et al. Early experience with robotic lung resection results in similar operative outcomes and morbidity when compared with matched video-assisted thoracoscopic surgery cases. Ann Thorac Surg 2012;93:1598-604; discussion 1604-5. [Crossref] [PubMed]
  3. Jang HJ, Lee HS, Park SY, et al. Comparison of the early robot-assisted lobectomy experience to video-assisted thoracic surgery lobectomy for lung cancer: a single-institution case series matching study. Innovations (Phila) 2011;6:305-10. [Crossref] [PubMed]
  4. Craig SR, Walker WS. A proposed anatomical classification of the pulmonary fissures. J R Coll Surg Edinb 1997;42:233-4. [PubMed]
  5. Miyajima M, Maki R, Tada M, et al. Vessel sealing system for video-assisted lung resection for cancer reduces chylothorax and bleeding. J Thorac Dis 2021;13:3458-66. [Crossref] [PubMed]
  6. Cerfolio RJ, Bryant AS, Skylizard L, et al. Initial consecutive experience of completely portal robotic pulmonary resection with 4 arms. J Thorac Cardiovasc Surg 2011;142:740-6. [Crossref] [PubMed]
  7. McKenna RJ Jr, Houck W, Fuller CB. Video-assisted thoracic surgery lobectomy: experience with 1,100 cases. Ann Thorac Surg 2006;81:421-5; discussion 425-6. [Crossref] [PubMed]
  8. Ceppa DP, Kosinski AS, Berry MF, et al. Thoracoscopic lobectomy has increasing benefit in patients with poor pulmonary function: a Society of Thoracic Surgeons Database analysis. Ann Surg 2012;256:487-93. [Crossref] [PubMed]
  9. Smith CB, Kale M, Mhango G, et al. Comparative outcomes of elderly stage I lung cancer patients treated with segmentectomy via video-assisted thoracoscopic surgery versus open resection. J Thorac Oncol 2014;9:383-9. [Crossref] [PubMed]
  10. Kent MS, Hartwig MG, Vallières E, et al. Pulmonary Open, Robotic and Thoracoscopic Lobectomy (PORTaL) Study: An Analysis of 5,721 Cases. Ann Surg 2021; Epub ahead of print. [Crossref] [PubMed]
  11. Oh DS, Reddy RM, Gorrepati ML, et al. Robotic-Assisted, Video-Assisted Thoracoscopic and Open Lobectomy: Propensity-Matched Analysis of Recent Premier Data. Ann Thorac Surg 2017;104:1733-40. [Crossref] [PubMed]
  12. Cerfolio RJ, Bess KM, Wei B, et al. Incidence, Results, and Our Current Intraoperative Technique to Control Major Vascular Injuries During Minimally Invasive Robotic Thoracic Surgery. Ann Thorac Surg 2016;102:394-9. [Crossref] [PubMed]
  13. Ueno H, Watanabe Y, Hirayama S, et al. Intraoperative complications and troubles in robot-assisted anatomical pulmonary resection. Gen Thorac Cardiovasc Surg 2021;69:51-8. [Crossref] [PubMed]
  14. Swanson SJ, Miller DL, McKenna RJ Jr, et al. Comparing robot-assisted thoracic surgical lobectomy with conventional video-assisted thoracic surgical lobectomy and wedge resection: results from a multihospital database (Premier). J Thorac Cardiovasc Surg 2014;147:929-37. [Crossref] [PubMed]
  15. Saracino A, Deguet A, Staderini F, et al. Haptic feedback in the da Vinci Research Kit (dVRK): A user study based on grasping, palpation, and incision tasks. Int J Med Robot 2019;15:e1999. [Crossref] [PubMed]
  16. Zhao B, Nelson CA. A sensorless force-feedback system for robot-assisted laparoscopic surgery. Comput Assist Surg (Abingdon) 2019;24:36-43. [Crossref] [PubMed]
  17. Veronesi G, Galetta D, Maisonneuve P, et al. Four-arm robotic lobectomy for the treatment of early-stage lung cancer. J Thorac Cardiovasc Surg 2010;140:19-25. [Crossref] [PubMed]
  18. Wilson JL, Louie BE, Cerfolio RJ, et al. The prevalence of nodal upstaging during robotic lung resection in early stage non-small cell lung cancer. Ann Thorac Surg 2014;97:1901-6; discussion 1906-7. [Crossref] [PubMed]
  19. Lee BE, Shapiro M, Rutledge JR, et al. Nodal Upstaging in Robotic and Video Assisted Thoracic Surgery Lobectomy for Clinical N0 Lung Cancer. Ann Thorac Surg 2015;100:229-33; discussion 233-4. [Crossref] [PubMed]
  20. Hospital Intelligence Agency. Diagnosis procedure combination statistics. Accessed November 2, 2020. Available online: https://hospia.jp/dpc
  21. Kwon ST, Zhao L, Reddy RM, et al. Evaluation of acute and chronic pain outcomes after robotic, video-assisted thoracoscopic surgery, or open anatomic pulmonary resection. J Thorac Cardiovasc Surg 2017;154:652-9.e1. [Crossref] [PubMed]
  22. Huang J, Tian Y, Li C, et al. Robotic-assisted thoracic surgery reduces perioperative complications and achieves a similar long-term survival profile as posterolateral thoracotomy in clinical N2 stage non-small cell lung cancer patients: a multicenter, randomized, controlled trial. Transl Lung Cancer Res 2021;10:4281-92. [Crossref] [PubMed]
  23. Gharagozloo F, Margolis M, Tempesta B, et al. Robot-assisted lobectomy for early-stage lung cancer: report of 100 consecutive cases. Ann Thorac Surg 2009;88:380-4. [Crossref] [PubMed]
Cite this article as: Miyajima M, Maki R, Arai W, Tsuruta K, Shindo Y, Nakamura Y, Watanabe A. Robot-assisted vs. video-assisted thoracoscopic surgery in lung cancer. J Thorac Dis 2022;14(6):1890-1899. doi: 10.21037/jtd-21-1696

Download Citation